ZCR-2060

N/A

Report date: 2022/08/23 20:00:44

Base Information

Drug NameZCR-2060
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistamine H1 receptor antagonists
TargetsHistamine H1 receptor
Therapy Area/IndicationsDermatitisRhinitis, AllergicAsthma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesZeria
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesZeria
Active IndicationsN/A
Inactive IndicationsDermatitisRhinitis, AllergicAsthma

Other Information

ATC CodeN/A
Related LinksN/A